We are interested in understanding and improving the treatment
of 2 very common disorders of reproduction that may result in
failure to ovulate (release an egg) and consequently impaired
fertility, namely polycystic ovary syndrome (PCOS) (which is also
associated with an increased risk of developing diabetes in later
life) and premature menopause.

A woman is born with all the eggs she will ever have. Of the
half a million or so eggs she has when she starts her periods,
only about 400 will be ovulated (released) during the monthly
cycle over her reproductive lifetime. The rest will degenerate
and die, mostly long before they reach maturity. The eggs are
stored in the cortex (outer layer) of the ovary, each one in a
very small follicle comprising the egg itself surrounded
by a single thin layer of supporting cells. They may stay in this
resting state for up to 50 years before starting to
grow but, surprisingly, very little is known about what triggers
the growth of these early follicles or how a steady supply of
growing eggs is maintained throughout reproductive life. We do
know that when this process is disturbed the ovary may have too
many follicles (as in polycystic ovary syndrome) or too few (resulting
in an early menopause).
Our research has focused on studying these very early stages of development
of the egg and its follicle, and the molecules that might be involved
in this process. We have been fortunate in being able to obtain
tiny pieces of ovarian cortex from small biopsies taken from women
at the time of routine laparoscopy, usually as part of infertility
investigations in women between 21 and 40 years of age (with,
of course, local Ethical Committee approval and with the informed,
written consent of the patients). We have already been able to
show that these crucial early stages of follicle development are
abnormal in PCOS (and have published our findings in the Lancet)
but much more needs to be done to find out why these abnormalities
occur.
Iif
you wish to donate to this research please click here